Infantile spasms

Neurologist

Volumn 16, Issue 2, 2010, Pages 69-75

  Kossoff, Eric H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

ACTH; Hypsarrhythmia; Infantile spasms; Ketogenic diet; Prednisolone; Vigabatrin; West syndrome

Indexed keywords

CORTICOTROPIN; ETIRACETAM; GANAXOLONE; NITRAZEPAM; PLACEBO; PREDNISOLONE; PYRIDOXINE; SULTIAME; SYNTHACTEN; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

BEHAVIOR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DRUG COST; DRUG DOSE SEQUENCE; DRUG MEGADOSE; EDEMA; ELECTROENCEPHALOGRAPHY; HEALTH SURVEY; HUMAN; HYPERTENSION; HYPSARRHYTHMIA; INFANTILE SPASM; INFECTION; INJECTION SITE IRRITATION; IRRITABILITY; KETOGENIC DIET; LOW DRUG DOSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; REVIEW; SIDE EFFECT; STOMACH HEMORRHAGE; TUBEROUS SCLEROSIS; VISUAL FIELD DEFECT; WEIGHT GAIN;

ANIMALS; HUMANS; INFANT; SPASMS, INFANTILE;

EID: 77949465465     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3181d1416c     Document Type: Review

References (56)

1. West WJ. On a peculiar form of infantile convulsions. Lancet. 1841;1:724-725.
2. Stafstrom CE. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr. 2009;9:75-81.
3. Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia. 2004;45:1416-1428.
4. Gibbs EL, Anderson EM, Gibbs FA. Diagnosis and prognosis of hypsarrhythmia and infantile spasms. Pediatrics. 1954;13:66-73.
5. Hrachovy RA, Frost JD Jr, Glaze DG. Hypsarrhythmia: variations on the theme. Epilepsia. 1984;25:317-325.
6. Riikonen RS. Favourable prognosis factors with infantile spasms. Eur J Paediatr Neurol. 2010;14:13-18.
7. Hrachovy RA, Frost JD Jr, Kellaway P, et al. Double-blind study of ACTH vs. prednisone therapy in infantile spasms. J Pediatr. 1983;103:641-645.
8. Riikonen RS. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics. 1982;13:14-23.
9. Kossoff EH, Hedderick EF, Turner Z, et al. A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia. 2008;49:1504-1509.
10. Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45:255-262.
11. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004;364:1773-1778.
12. Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotrophin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996;97:375-379.
13. Hrachovy RA, Frost JD Jr, Glaze DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr. 1994;124:803-806.
14. Kossoff EH, Hartman AL, Rubenstein JE, et al. High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav. 2009;14:674-676.
15. Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol. 1991;(suppl 2):S52-S59.
16. Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40:1627-1633.
17. Elterman RD, Shields WD, Mansfield KA, et al. Randomised trial of vigabatrin in patients with infantile spasms. Neurology. 2001;57:1416-1421.
18. Fejerman N, Cersosimo R, Caraballo R, et al. Vigabatrin as a first choice drug in the treatment of West syndrome. J Child Neurol. 2000;15:161-165.
19. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia. 1997;38:1270-1274.
20. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712-717.
21. Fisher E, Siemes H, Pund R, et al. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia. 1992; 33:165-171.
22. Siemes H, Spohr HL, Michael T, et al. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia. 1988;29:553-560.
23. Chamberlain MC. Nitrazepam for refractory infantile spasms and the Lennox- Gastaut syndrome. J Child Neurol. 1996;11:31-34.
24. Volzke E, Doose H, Stephan E. The treatment of infantile spasms and hypsarrhythmia with mogadon. Epilepsia. 1967;8:64-70.
25. Debus OM, Kurlemann G. Sulthiame in the primary therapy of West syndrome: a randomised double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia. 2004;45:103-108.
26. Yanai S, Hanai T, Narazaki O. Treatment of infantile spasms with zonisamide. Brain Dev. 1999;21:157-161.
27. Suzuki Y, Nagai T, Ono J, et al. Zonisamide monotherapy in newly diagnosed infantile spasms. Epilepsia. 1997;38:1035-1038.
28. Hosain SA, Merchant S, Solomon GE, et al. Topiramate for the treatment of infantile spasms. J Child Neurol. 2006;21:17-19.
29. Kwon YS, Jun YH, Hong YJ, et al. Topiramate monotherapy in infantile spasm. Yonsei Med J. 2006;47:498-504.
30. Peltzer B, Alonso WD, Porter BE. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol. 2009;24:400-405.
31. Ohtsuka Y, Matsuda M, Ogino T, et al. Treatment of the West syndrome with high-dose pyridoxal phosphate. Brain Dev. 1987;9:418-421.
32. Pietz J, Benninger C, Schafer H, et al. Treatment of infantile spasms with high-dosage vitamin B6. Epilepsia. 1993;34:757-763.
33. Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62:1668-1681.
34. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol. 2005;20(suppl 1):S1-S56.
35. Wheless JW, Clarke DF, Arzimanoglou A, et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007;9:353-412.
36. Hancock E, Osborne JP, Milner P. The treatment of West syndrome: a Cochrane review of the literature to December 2000. Brain Dev. 2001;23: 624-634.
37. Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia. 2009;50:163-173.
38. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone dysfunction. Electroretinogram and ophthalmologic findings. Neurology. 1997;50:614-618.
39. Pearl PL, Vezina LG, Saneto RP, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009;50:184-194.
40. Sinha SR, Kossoff EH. The ketogenic diet. Neurologist. 2005;11:161-170.
41. Nordli DR Jr, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics. 2001;108:129-133.
42. Kossoff EH, Pyzik PL, McGrogan JR, et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002;109:780-783.
43. Eun SH, Kang HC, Kim DW, et al. Ketogenic diet for treatment of infantile spasms. Brain Dev. 2006;28:566-571.
44. Zou LP, Lin Q, Qin J, et al. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms. Clin Neuropharmacol. 2008;31: 86-92.
45. Korinthenberg R, Schreiner A. Topiramate in children with West syndrome: a retrospective multicenter evaluation of 100 patients. J Child Neurol. 2007;22:302-306.
46. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. 1998;39:1324-1328.
47. Mikati MA, El Banna D, Sinno D, et al. Response of infantile spasms to levetiracetam. Neurology. 2008;70:574-575.
48. Kerrigan JF, Shields WD, Nelson TY, et al. Ganaxolone for treating infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 2000;42:133-139.
49. Chugani HT, Shewmon DA, Shields WD, et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia. 1993;34:764-771.
50. Loddenkemper T, Holland KD, Stanford LD, et al. Developmental outcome after epilepsy surgery in infancy. Pediatrics. 2007;119:930-935.
51. Cross JH, Jayakar P, Nordli D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia. 2006;47:952-959.
52. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia. 1996;37:367-372.
53. Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia. 2006;47:2202-2205.
54. Koo B, Hwang PA, Logan WJ. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology. 1993;43:2322-2327.
55. Jeavons PM, Harper JR, Bower BD. Long-term prognosis in infantile spasms: a follow-up report on 112 cases. Dev Med Child Neurol. 1970;12:413-421.
56. Matsumoto A, Watanabe K, Negoro T, et al. Long-term prognosis after infantile spasms: a statistical study of prognostic factors in 200 cases. Dev Med Child Neurol. 1981;23:51-65.